{"id":"W4385727291","doi":"10.1097/01.hs9.0000970360.06967.6b","title":"P864: A PHASE 1 STUDY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN INTERIM ANALYSIS OF DREAMM-9","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Interim analysis; Bortezomib; Internal medicine; Adverse effect; Tolerability; Clinical endpoint; Dexamethasone; Gastroenterology; Oncology; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004633061,0.001338706,0.002152434,0.0004257553,0.0005960393,0.00169468,0.001121184,0.001156104,0.003683719],"category_scores_gemma":[0.002061318,0.0006042341,0.00251391,0.0004026784,0.0007088572,0.001102311,0.0005891591,0.004128293,0.001176869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001191687,"about_ca_system_score_gemma":0.002429781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009385711,"about_ca_topic_score_gemma":0.001857656,"domain_scores_codex":[0.9989461,0.0005363031,0.00005047924,0.0001422,0.0001315561,0.0001933632],"domain_scores_gemma":[0.9988282,0.000194519,0.0002724953,0.0001567118,0.0001183586,0.0004295834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8073718,0.04993618,0.01028844,0.0008150339,0.004788848,0.0002358355,0.0002850104,0.005305589,0.01871608,0.000520313,0.01188533,0.08985164],"study_design_scores_gemma":[0.5569834,0.4040879,0.02174928,0.00006650824,0.002120307,0.000344699,0.00007427226,0.002607517,0.004484892,0.00059457,0.00683602,0.00005072193],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784855,0.002904729,0.001888617,0.001074637,0.0003229582,0.00475572,0.006262243,0.0002594203,0.004046171],"genre_scores_gemma":[0.9638191,0.002099019,0.005471,0.00199984,0.0002323409,0.006043891,0.01431781,0.0001247624,0.005892359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004633061,"threshold_uncertainty_score":0.02450222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0287828468739242,"score_gpt":0.3530728733145616,"score_spread":0.3242900264406374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}